Edward Tabor

6.0k total citations
146 papers, 4.3k citations indexed

About

Edward Tabor is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Edward Tabor has authored 146 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 87 papers in Hepatology and 26 papers in Oncology. Recurrent topics in Edward Tabor's work include Hepatitis B Virus Studies (87 papers), Hepatitis C virus research (50 papers) and Liver Disease Diagnosis and Treatment (34 papers). Edward Tabor is often cited by papers focused on Hepatitis B Virus Studies (87 papers), Hepatitis C virus research (50 papers) and Liver Disease Diagnosis and Treatment (34 papers). Edward Tabor collaborates with scholars based in United States, Japan and United Kingdom. Edward Tabor's co-authors include Robert J. Gerety, Chu Chieh Hsia, R. J. Gerety, Robert H. Purcell, Richard E. Sampliner, L. A. Smallwood, Yutaka Nakashima, Milton April, Jay S. Epstein and Lewellys F. Barker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Edward Tabor

145 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Tabor United States 39 2.7k 2.5k 637 581 488 146 4.3k
Takeshi Tanaka Japan 33 2.4k 0.9× 2.6k 1.1× 615 1.0× 499 0.9× 218 0.4× 100 4.3k
Johnson Y. N. Lau United States 38 3.4k 1.3× 3.9k 1.6× 1.1k 1.7× 1.0k 1.8× 374 0.8× 96 5.7k
Toshio Shikata Japan 33 2.1k 0.8× 2.3k 0.9× 624 1.0× 440 0.8× 374 0.8× 178 4.0k
Valérie Thiers France 37 3.6k 1.3× 3.7k 1.5× 517 0.8× 334 0.6× 209 0.4× 91 4.6k
Leonardo Bianchi Italy 32 5.1k 1.9× 5.1k 2.1× 336 0.5× 810 1.4× 443 0.9× 172 7.9k
Ran Tur‐Kaspa Israel 33 2.5k 0.9× 2.5k 1.0× 387 0.6× 445 0.8× 293 0.6× 134 3.9k
Robert S. Kauffman United States 32 3.3k 1.2× 3.5k 1.4× 1.5k 2.4× 1.1k 1.8× 263 0.5× 58 6.3k
William L. Irving United Kingdom 38 3.2k 1.2× 2.9k 1.2× 876 1.4× 387 0.7× 277 0.6× 209 5.1k
Giovanni Raimondo Italy 44 7.0k 2.6× 6.4k 2.6× 624 1.0× 905 1.6× 372 0.8× 159 8.2k
Ih‐Jen Su Taiwan 42 2.0k 0.7× 973 0.4× 1.6k 2.6× 1.2k 2.0× 1.0k 2.1× 105 5.1k

Countries citing papers authored by Edward Tabor

Since Specialization
Citations

This map shows the geographic impact of Edward Tabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tabor more than expected).

Fields of papers citing papers by Edward Tabor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Tabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tabor. The network helps show where Edward Tabor may publish in the future.

Co-authorship network of co-authors of Edward Tabor

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Tabor. A scholar is included among the top collaborators of Edward Tabor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Tabor. Edward Tabor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabor, Edward. (2020). Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products. Journal of Parenteral and Enteral Nutrition. 44(2). 174–181. 4 indexed citations
2.
Tabor, Edward. (2019). Current Status of Multi‐Trace Element Products for Parenteral Nutrition in the United States. Nutrition in Clinical Practice. 34(4). 487–488. 2 indexed citations
3.
Tabor, Edward. (2015). Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients. Therapeutic Innovation & Regulatory Science. 49(5). 666–672. 3 indexed citations
4.
Gao, Guangyu, Sherri O. Stuver, Akira Okayama, et al.. (2005). The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies: a comparison of subjects with and without liver cancer. Journal of Viral Hepatitis. 12(1). 46–50. 2 indexed citations
5.
Biswas, Robin, Edward Tabor, Chu Chieh Hsia, et al.. (2003). Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 43(6). 788–798. 208 indexed citations
6.
Tabor, Edward. (2002). Viruses and liver cancer. Elsevier eBooks. 15 indexed citations
7.
Tabor, Edward & Jay S. Epstein. (2002). NAT screening of blood and plasma donations: evolution of technology and regulatory policy*. Transfusion. 42(9). 1230–1237. 40 indexed citations
8.
Okayama, Akira, Sherri O. Stuver, Edward Tabor, et al.. (2002). Incident hepatitis C virus infection in a community‐based population in Japan. Journal of Viral Hepatitis. 9(1). 43–51. 39 indexed citations
9.
Cowan, Elliot P., George J. Nemo, Alan Williams, et al.. (1999). Absence of human T‐lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study. Transfusion. 39(8). 904–909. 11 indexed citations
10.
Nakashima, Yutaka, O Nakashima, Chu Chieh Hsia, Masamichi Kojiro, & Edward Tabor. (1999). Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver International. 19(1). 12–18. 108 indexed citations
11.
Hsia, Chu Chieh, et al.. (1997). Binding of Wild-Type P53 by Topoisomerase II and Overexpression of Topoisomerase II in Human Hepatocellular Carcinoma. Biochemical and Biophysical Research Communications. 234(1). 194–197. 17 indexed citations
12.
Hadziyannis, Stephanos J., Edward Tabor, Αναστασία Τζώνου, et al.. (1995). A case‐control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. International Journal of Cancer. 60(5). 627–631. 67 indexed citations
13.
Tabor, Edward, et al.. (1992). Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines. Journal of Medical Virology. 38(4). 235–239. 29 indexed citations
14.
Tabor, Edward, et al.. (1992). Increased expression of transforming growth factor α after transfection of a human hepatoblastoma cell line with the hepatitis B virus. Journal of Medical Virology. 37(4). 271–273. 21 indexed citations
15.
Tabor, Edward, et al.. (1991). Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine. Journal of Medical Virology. 34(1). 45–50. 7 indexed citations
16.
Tabor, Edward, et al.. (1990). Antibody responses of adults, adolescents, and children to a plasma‐derived hepatitis B vaccine in a rural African setting. Journal of Medical Virology. 32(2). 134–138. 5 indexed citations
17.
Tabor, Edward. (1989). Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infection. Journal of Medical Virology. 27(1). 1–6. 26 indexed citations
18.
Tabor, Edward & Robert J. Gerety. (1979). Hepatitis B virus infection in infants and toddlers in Nigeria: The need for early intervention. The Journal of Pediatrics. 95(4). 647–650. 14 indexed citations
19.
Tabor, Edward, Robert J. Gerety, Jay H. Hoofnagle, & Lewellys F. Barker. (1976). Immune response in fulminant viral hepatitis, type B.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 71(4). 635–40. 9 indexed citations
20.
Barlow, Barbara, Edward Tabor, William A. Blanc, Thomas V. Santulli, & Ruth C. Harris. (1976). Choledochal cyst: A review of 19 cases. The Journal of Pediatrics. 89(6). 934–940. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Tanaka Breakdown of academic impact, for papers by Johnson Y. N. Lau Breakdown of academic impact, for papers by Toshio Shikata Breakdown of academic impact, for papers by Valérie Thiers Breakdown of academic impact, for papers by Leonardo Bianchi Breakdown of academic impact, for papers by Ran Tur‐Kaspa Breakdown of academic impact, for papers by Robert S. Kauffman Breakdown of academic impact, for papers by William L. Irving Breakdown of academic impact, for papers by Giovanni Raimondo Breakdown of academic impact, for papers by Ih‐Jen Su
Rankless by CCL
2026